D96 | TLD turnaround: increasing rates of Dolutegravir-based regimens among women of childbearing age in Zimbabwe | E-poster | Antiretroviral therapy, including treatment as prevention |
D96 | Stigma, survival, and social support: exploring lived experiences of antiretroviral therapy among young gay and bisexual men, sex workers, and transgender women living with HIV in Jamaica | E-poster | Antiretroviral therapy, including treatment as prevention |
D97 | Perceived acceptability of broadly neutralizing antibodies (bnAbs) for HIV prevention among young men who have sex with men at risk for HIV infection in the United States | E-poster | Pre-exposure prophylaxis |
D97 | Acceptability of and preferences for next generation PrEP products among young men who have sex with men | E-poster | Pre-exposure prophylaxis |
D97 | Pre-exposure prophylaxis as an additional HIV prevention choice in Uganda - the role of a responsive supply chain system | E-poster | Pre-exposure prophylaxis |
D97 | Challenges of recommencing HIV pre-exposure prophylaxis (PrEP) use during the COVID-19 pandemic | E-poster | Pre-exposure prophylaxis |
D97 | Assessing level of exposure and predictors of intention to use HIV pre-exposure prophylaxis among adolescent girls and young women exposed to Jipende JiPrEP campaign in Kisumu, Kenya | E-poster | Pre-exposure prophylaxis |
D97 | Health care system- and provider-level barriers to utilization of oral pre-exposure prophylaxis (PrEP) among young men who have sex with men and lessons for implementation of next generation modalities | E-poster | Pre-exposure prophylaxis |
D97 | Characteristics of gay and bisexual men who use event-based PrEP dosing regimens using national Australian data 2019-2020 | E-poster | Pre-exposure prophylaxis |
D97 | Service providers' acceptability of the HIV PrEP program: current situation and associated factors | E-poster | Pre-exposure prophylaxis |